GlassScriptPhysician profile
Beth L Dektas
NPI 1790078673
$1,103.37
in general payments reported to CMS, 2019-2025
15 companies · $491 in 2025
The $491 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.32 · 2020: $17.94 · 2022: $137 · 2024: $397 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $804 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.78 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $323.03 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $238.54 | 2022-2025 | |
| Sage Therapeutics, LLC | $121.06 | 2024-2025 | Zurzuvae |
| Gynesonics, INC. | $112.52 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $82.45 | 2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $45.36 | 2019-2025 | |
| Exeltis, USA INC. | $29.27 | 2025 | Slynd |
| Abbvie INC. | $27.64 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $20.82 | 2025 | Qelbree |
| Myovant Sciences INC. | $20.65 | 2022 | |
| Optumhealth Care Solutions, LLC | $20.42 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Hologic Sales and Service, LLC | $19.78 | 2019 | |
| Pfizer INC. | $19.01 | 2024 | |
| Meditrina | $11.64 | 2024 | |
| Therapeuticsmd, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Dektas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.